The exact mechanisms through which COX-2 is upregulated in breast cancer are not completely understood yet, but one possible explanation is that the expression of this enzyme in breast cancer cells is more active than in normal tissue because of intrinsic mechanisms. Here, PTGS2 is linked to breast cancer.